Menicon Co Ltd
TSE:7780
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 126
2 439
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Menicon Co Ltd
Other Equity
Menicon Co Ltd
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Menicon Co Ltd
TSE:7780
|
Other Equity
ÂĄ8.6B
|
CAGR 3-Years
384%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Hoya Corp
TSE:7741
|
Other Equity
ÂĄ207.6B
|
CAGR 3-Years
430%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
52%
|
||
H
|
Hogy Medical Co Ltd
TSE:3593
|
Other Equity
ÂĄ3.9B
|
CAGR 3-Years
166%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
Shofu Inc
TSE:7979
|
Other Equity
ÂĄ4.3B
|
CAGR 3-Years
84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
55%
|
||
Mani Inc
TSE:7730
|
Other Equity
ÂĄ5.1B
|
CAGR 3-Years
115%
|
CAGR 5-Years
183%
|
CAGR 10-Years
33%
|
||
Nipro Corp
TSE:8086
|
Other Equity
ÂĄ59.3B
|
CAGR 3-Years
184%
|
CAGR 5-Years
79%
|
CAGR 10-Years
18%
|
Menicon Co Ltd
Glance View
Menicon Co., Ltd. engages in the manufacture and sale of contact lenses. The company is headquartered in Nagoya, Aichi-Ken and currently employs 3,860 full-time employees. The company went IPO on 2015-06-25. The firm has two business segments. With its subsidiaries, the Contact Lens segment is engaged in manufacture and sales of contact lens, care supplies and other goods. The Others segment is engaged in development and sales of veterinary medical products, decomposition accelerator of rice straw, composting accelerator of livestock excrement, assisted reproductive medicine and products of advanced medical fields, as well as management of contact lens retailer staff training school and provision of temporary staffing service, among others.
See Also
What is Menicon Co Ltd's Other Equity?
Other Equity
8.6B
JPY
Based on the financial report for Sep 30, 2024, Menicon Co Ltd's Other Equity amounts to 8.6B JPY.
What is Menicon Co Ltd's Other Equity growth rate?
Other Equity CAGR 3Y
384%
Over the last year, the Other Equity growth was 68%. The average annual Other Equity growth rates for Menicon Co Ltd have been 384% over the past three years .